Literature DB >> 1436286

Plasma levels of the anaphylatoxins C3a and C4a in patients with IgA nephropathy/Henoch-Schönlein nephritis.

H H Abou-Ragheb1, A J Williams, C B Brown, A Milford-Ward.   

Abstract

Measurements of plasma anaphylatoxins C3a and C4a were carried out as an indicator of in vivo complement activation in 46 patients suffering from IgA nephropathy/Henoch-Schönlein nephritis. There was a significant correlation between plasma levels of C4a and plasma creatinine and urea. We also found a significant correlation of plasma levels of C3a with plasma creatinine. We propose that the measurement of anaphylatoxin levels provides a sensitive indicator of in vivo complement activation and may serve as an additional method for monitoring the progress of disease in these patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1436286     DOI: 10.1159/000186989

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  8 in total

Review 1.  Clinical utility of complement assessment.

Authors:  A E Ahmed; J B Peter
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

2.  C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy.

Authors:  Lu Liu; Ying Zhang; Ximei Duan; Qi Peng; Quan Liu; Yali Zhou; Songxia Quan; Guolan Xing
Journal:  J Clin Immunol       Date:  2013-12-12       Impact factor: 8.317

3.  Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.

Authors:  Y Zhang; X Yan; T Zhao; Q Xu; Q Peng; R Hu; S Quan; Y Zhou; G Xing
Journal:  Clin Exp Immunol       Date:  2017-04-10       Impact factor: 4.330

4.  Higher Serum Angiotensinogen Is an Indicator of IgA Vasculitis with Nephritis Revealed by Comparative Proteomes Analysis.

Authors:  Xuelian He; Wei Yin; Yan Ding; Shu-jian Cui; Jiangwei Luan; Peiwei Zhao; Xin Yue; Chunhua Yu; Xiaohui Laing; YuLan Zhao
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

Review 5.  Therapeutic regulation of complement in patients with renal disease - where is the promise?

Authors:  Johua M Thurman
Journal:  Clin Nephrol       Date:  2012-05       Impact factor: 0.975

Review 6.  The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy.

Authors:  Dana V Rizk; Nicolas Maillard; Bruce A Julian; Barbora Knoppova; Todd J Green; Jan Novak; Robert J Wyatt
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

7.  Identification of key genes, pathways and potential therapeutic agents for IgA nephropathy using an integrated bioinformatics analysis.

Authors:  Xiaoxue Chen; Mindan Sun
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Apr-Jun       Impact factor: 1.636

Review 8.  The Complement C3a and C3a Receptor Pathway in Kidney Diseases.

Authors:  Shuang Gao; Zhao Cui; Ming-Hui Zhao
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.